DR. REDDY'S LABORATORIES-ADR (RDY) Stock Analyst Earnings Estimates
NYSE:RDY - New York Stock Exchange, Inc. - US2561352038 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 246.697B 14.50% | 280.111B 13.54% | 326.439B 16.54% | 350.314B 7.31% | 356.949B 1.89% | 387.758B 8.63% | 407.543B 5.10% | N/A | |
| EBITDA YoY % growth | 65.4B 39.21% | 79.334B 21.31% | 87.164B 9.87% | 93.316B 7.06% | 79.346B -14.97% | 86.698B 9.27% | 114.603B 32.19% | 187.691B 63.77% | |
| EBIT YoY % growth | 52.898B 49.73% | 64.634B 22.19% | 70.127B 8.50% | 74.271B 5.91% | 60.542B -18.49% | 65.773B 8.64% | 92.782B 41.06% | 179.7B 93.68% | |
| Operating Margin | 21.44% | 23.07% | 21.48% | 21.20% | 16.96% | 16.96% | 22.77% | N/A | |
| EPS YoY % growth | 54.24 90.38% | 66.95 23.45% | 67.85 1.35% | 72.87 7.40% | 58.42 -19.83% | 63.56 8.80% | N/A | N/A |
All data in INR
| Q2 / 26 | Q3 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 17.96 19.23% | 14.86 -12.34% |
| Revenue Q2Q % growth | 89.94B 11.89% | 86.891B 3.67% |
| EBITDA Q2Q % growth | 22.195B -12.94% | 19.938B -13.77% |
| EBIT Q2Q % growth | 18.733B 5.72% | 14.584B -19.03% |
All data in INR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 17.04 1.94% | 18.27 | -1.23 | -6.74% |
| Q4 2025 Q2Q % growth | 19.12 21.89% | 18.60 | 0.52 | 2.77% |
| Q3 2025 Q2Q % growth | 16.96 2.28% | 17.52 | -0.57 | -3.24% |
| Q2 2025 Q2Q % growth | 15.06 -15.36% | 17.34 | -2.27 | -13.10% |
| Q1 2025 Q2Q % growth | 16.71 -1.04% | 15.66 | 1.05 | 6.71% |
| Q4 2024 Q2Q % growth | 15.69 35.84% | 14.97 | 0.72 | 4.81% |
| Q3 2024 Q2Q % growth | 16.58 10.77% | 15.10 | 1.48 | 9.80% |
| Q2 2024 Q2Q % growth | 17.80 32.74% | 14.80 | 3.00 | 20.25% |
| Q1 2024 Q2Q % growth | 16.89 18.00% | 12.40 | 4.48 | 36.15% |
| Q4 2023 Q2Q % growth | 11.55 889.37% | 9.80 | 1.74 | 17.78% |
| Q3 2023 Q2Q % growth | 14.97 75.99% | 13.22 | 1.75 | 13.23% |
| Q2 2023 Q2Q % growth | 13.41 12.29% | 9.64 | 3.77 | 39.15% |
| Q1 2023 Q2Q % growth | 14.31 108.18% | 7.78 | 6.54 | 84.05% |
| Q4 2022 Q2Q % growth | 1.17 -82.49% | 8.10 | -6.93 | -85.59% |
| Q3 2022 Q2Q % growth | 8.50 3,469.75% | 8.98 | -0.48 | -5.31% |
| Q2 2022 Q2Q % growth | 11.94 30.15% | 8.22 | 3.72 | 45.28% |
| Q1 2022 Q2Q % growth | 6.87 -1.49% | 8.05 | -1.18 | -14.61% |
| Q4 2021 Q2Q % growth | 6.66 -27.71% | 7.96 | -1.29 | -16.25% |
| Q3 2021 Q2Q % growth | 0.24 103.46% | 8.81 | -8.57 | -97.30% |
| Q2 2021 Q2Q % growth | 9.18 -30.37% | 7.45 | 1.72 | 23.09% |
| Q1 2021 Q2Q % growth | 6.98 -12.65% | 6.20 | 0.78 | 12.57% |
| Q4 2020 Q2Q % growth | 9.22 76.03% | 6.56 | 2.65 | 40.44% |
| Q3 2020 Q2Q % growth | -6.88 -217.67% | 6.00 | -12.88 | -214.68% |
| Q2 2020 Q2Q % growth | 13.18 117.16% | 6.87 | 6.31 | 91.86% |
| Q1 2020 Q2Q % growth | 7.99 45.39% | 5.59 | 2.40 | 42.99% |
| Q4 2019 Q2Q % growth | 5.24 | 4.90 | 0.34 | 6.95% |
| Q3 2019 Q2Q % growth | 5.85 | 4.70 | 1.14 | 24.29% |
| Q2 2019 Q2Q % growth | 6.07 | 4.26 | 1.81 | 42.61% |
| Q1 2019 Q2Q % growth | 5.50 | 3.73 | 1.77 | 47.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 85.721B 11.38% | 89.177B | -3.456B | -3.88% |
| Q4 2025 Q2Q % growth | 85.284B 19.89% | 85.641B | -357M | -0.42% |
| Q3 2025 Q2Q % growth | 83.812B 15.81% | 82.986B | 826M | 1.00% |
| Q2 2025 Q2Q % growth | 80.382B 16.45% | 78.202B | 2.18B | 2.79% |
| Q1 2025 Q2Q % growth | 76.961B 13.88% | 74.271B | 2.69B | 3.62% |
| Q4 2024 Q2Q % growth | 71.138B 12.65% | 72.58B | -1.442B | -1.99% |
| Q3 2024 Q2Q % growth | 72.368B 6.58% | 70.667B | 1.701B | 2.41% |
| Q2 2024 Q2Q % growth | 69.026B 9.01% | 69.536B | -510M | -0.73% |
| Q1 2024 Q2Q % growth | 67.579B 29.14% | 66.455B | 1.124B | 1.69% |
| Q4 2023 Q2Q % growth | 63.152B 15.35% | 61.607B | 1.545B | 2.51% |
| Q3 2023 Q2Q % growth | 67.898B 27.19% | 62.062B | 5.836B | 9.40% |
| Q2 2023 Q2Q % growth | 63.318B 9.42% | 58.494B | 4.824B | 8.25% |
| Q1 2023 Q2Q % growth | 52.329B 5.82% | 54.772B | -2.443B | -4.46% |
| Q4 2022 Q2Q % growth | 54.749B 14.82% | 52.723B | 2.026B | 3.84% |
| Q3 2022 Q2Q % growth | 53.383B 8.02% | 55.205B | -1.822B | -3.30% |
| Q2 2022 Q2Q % growth | 57.869B 17.84% | 52.999B | 4.87B | 9.19% |
| Q1 2022 Q2Q % growth | 49.451B 11.72% | 52.74B | -3.289B | -6.24% |
| Q4 2021 Q2Q % growth | 47.682B 7.18% | 49.377B | -1.695B | -3.43% |
| Q3 2021 Q2Q % growth | 49.419B 12.39% | 51.608B | -2.189B | -4.24% |
| Q2 2021 Q2Q % growth | 49.109B 2.04% | 47.456B | 1.653B | 3.48% |
| Q1 2021 Q2Q % growth | 44.265B 14.73% | 42.656B | 1.609B | 3.77% |
| Q4 2020 Q2Q % growth | 44.489B 10.41% | 43.094B | 1.395B | 3.24% |
| Q3 2020 Q2Q % growth | 43.971B 13.78% | 43.062B | 909M | 2.11% |
| Q2 2020 Q2Q % growth | 48.128B 26.07% | 43.273B | 4.855B | 11.22% |
| Q1 2020 Q2Q % growth | 38.582B 3.26% | 40.815B | -2.233B | -5.47% |
| Q4 2019 Q2Q % growth | 40.296B | 39.669B | 627M | 1.58% |
| Q3 2019 Q2Q % growth | 38.646B | 39.73B | -1.084B | -2.73% |
| Q2 2019 Q2Q % growth | 38.175B | 38.745B | -570M | -1.47% |
| Q1 2019 Q2Q % growth | 37.365B | 37.151B | 214M | 0.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.03% | 3.03% | 0.27% | -0.2% |
| Revenue | 1.62% | -1.01% | -2.39% | -2.51% |